Cuban President Miguel Díaz-Canel insisted on Monday on the need to review strategies to control the COVID-19 pandemic and deepen isolation protocols, emphasizing Havana.
The second anti-Covid-19 intervention trial in Cuba is beginning Monday with the vaccine candidate Abdala with 124,000 volunteers, among them health workers and the biopharmaceutical sector.
The president of Cuba, Miguel Diaz-Canel, praised the country’s progress in immunizing the population against Covid-19 with the use of vaccine candidates produced by the national biotechnology industry.
With the highest rate of patients recovered from COVID-19 in the Americas -94.2% as of March 20 - and two candidate vaccines in the final stage of clinical trials, Cuba is consolidating its national strategy to confront the pandemic, with results recently recognized by Bolivia’s President Luis Arce.
By mid-year, 70 percent of the Cuban population will be immunized against the SARS-Cov-2 virus as part of a vaccination strategy by population groups, scientists and health authorities explained Tuesday.